University of Notre Dame du Lac’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,336
| Closed | -$1.04M | – | 38 |
|
|
2020
Q1 | $1.04M | Sell |
12,336
-309
| -2% | -$26.1K | 0.32% | 39 |
|
|
2019
Q4 | $1.07M | Buy |
12,645
+234
| +2% | +$19.8K | 0.34% | 41 |
|
|
2019
Q3 | $837K | Sell |
12,411
-28,887
| -70% | -$1.95M | 0.25% | 47 |
|
|
2019
Q2 | $3.54M | Sell |
41,298
-13,956
| -25% | -$1.2M | 0.8% | 50 |
|
|
2019
Q1 | $4.91M | Buy |
55,254
+6,135
| +12% | +$545K | 1.1% | 38 |
|
|
2018
Q4 | $4.18M | Sell |
49,119
-4,774
| -9% | -$406K | 1.01% | 41 |
|
|
2018
Q3 | $5.23M | Sell |
53,893
-8,089
| -13% | -$784K | 0.97% | 42 |
|
|
2018
Q2 | $5.84M | Sell |
61,982
-4,599
| -7% | -$433K | 1.13% | 41 |
|
|
2018
Q1 | $5.4M | Buy |
66,581
+2,243
| +3% | +$182K | 1% | 42 |
|
|
2017
Q4 | $5.74M | Buy |
64,338
+3,252
| +5% | +$290K | 1.19% | 45 |
|
|
2017
Q3 | $5.69M | Buy |
61,086
+7,120
| +13% | +$663K | 1.58% | 14 |
|
|
2017
Q2 | $4.9M | Sell |
53,966
-2,068
| -4% | -$188K | 1.45% | 13 |
|
|
2017
Q1 | $4.92M | Buy |
+56,034
| New | +$4.92M | 1.23% | 45 |
|